Business Description
![Kuros Biosciences Ltd Kuros Biosciences Ltd logo](https://static.gurufocus.com/logos/0C00000WYP.png?14)
Kuros Biosciences Ltd
ISIN : CH0325814116
Compare
Compare
Traded in other countries / regions
KURN.Switzerland0RHR.UKCSBTF.USAYTSN.Germany Description
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.47 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 17.82 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 76.8 | |||||
3-Year EBITDA Growth Rate | 6.9 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 13.6 | |||||
3-Year Book Growth Rate | -15.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.91 | |||||
9-Day RSI | 63.99 | |||||
14-Day RSI | 63.91 | |||||
6-1 Month Momentum % | 136.79 | |||||
12-1 Month Momentum % | 564.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 156.89 | |||||
Days Sales Outstanding | 48.54 | |||||
Days Payable | 47.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -0.13 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.32 | |||||
Operating Margin % | -39.3 | |||||
Net Margin % | -40.9 | |||||
FCF Margin % | -26.92 | |||||
ROE % | -21.73 | |||||
ROA % | -17.7 | |||||
ROIC % | -22.47 | |||||
ROC (Joel Greenblatt) % | -482.8 | |||||
ROCE % | -20.26 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 13.56 | |||||
PB Ratio | 8.05 | |||||
Price-to-Tangible-Book | 28.57 | |||||
EV-to-EBIT | -32.96 | |||||
EV-to-EBITDA | -41.58 | |||||
EV-to-Revenue | 12.97 | |||||
EV-to-FCF | -48.46 | |||||
Price-to-Median-PS-Value | 1.04 | |||||
Price-to-Net-Current-Asset-Value | 36.84 | |||||
Earnings Yield (Greenblatt) % | -3.03 | |||||
FCF Yield % | -2.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CSBTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kuros Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 38.223 | ||
EPS (TTM) ($) | -0.433 | ||
Beta | 1.21 | ||
Volatility % | 126.08 | ||
14-Day RSI | 63.91 | ||
14-Day ATR ($) | 0.316242 | ||
20-Day SMA ($) | 13.6339 | ||
12-1 Month Momentum % | 564.02 | ||
52-Week Range ($) | 1.89 - 14.2 | ||
Shares Outstanding (Mil) | 36.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kuros Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kuros Biosciences Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kuros Biosciences Ltd Frequently Asked Questions
What is Kuros Biosciences Ltd(CSBTF)'s stock price today?
The current price of CSBTF is $14.00. The 52 week high of CSBTF is $14.20 and 52 week low is $1.89.
When is next earnings date of Kuros Biosciences Ltd(CSBTF)?
The next earnings date of Kuros Biosciences Ltd(CSBTF) is .
Does Kuros Biosciences Ltd(CSBTF) pay dividends? If so, how much?
Kuros Biosciences Ltd(CSBTF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |